Company profile for Impax Laboratories

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Impax Laboratories is a technology-based specialty pharmaceutical company utilizing our core competency in drug delivery and formulation expertise. We have a balanced business model consisting of; a successful generic business targeting high-value solid oral and alternative dosage form Abbreviated New Drug Applications (ANDA), and a branded business currently focused on internally developing Central Nervous System (CNS) produc...
Impax Laboratories is a technology-based specialty pharmaceutical company utilizing our core competency in drug delivery and formulation expertise. We have a balanced business model consisting of; a successful generic business targeting high-value solid oral and alternative dosage form Abbreviated New Drug Applications (ANDA), and a branded business currently focused on internally developing Central Nervous System (CNS) products where we can deliver meaningful patient benefits and develop strong intellectual property positions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
30831 Huntwood Ave.Hayward, CA 94544
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/dc-appeals-court-dismisses-ftc-case-against-endo-and-impaxs-opioid-agreement/

Zachary Brennan ENDPTS
28 Aug 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212886

FDA
18 Jan 2023

https://www.law360.com/lifesciences/articles/1513329?utm_source=feedly&utm_medium=rss&utm_campaign=section

Lauraann Wood LAW360
20 Jul 2022

https://news.bloomberglaw.com/pharma-and-life-sciences/endo-impax-beat-bid-for-special-procedures-at-antitrust-trial

BLOOMBERGLAW
23 Apr 2022

https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-settles-hetlioz-patent-litigation-with-msn-301461230.html

PRNEWSWIRE
14 Jan 2022

https://www.prnewswire.com/news-releases/labaton-sucharow-llp-and-freed-kanner-london--millen-llc-announce-pendency-of-class-action-involving-purchasers-of-opana-er-andor-its-generic-equivalent-301395695.html

PRNEWSWIRE
07 Oct 2021

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty